Subscribe by Email

About the Blog

The Active Ingredient features expert insights and commentary from leaders of ZS Associates' global pharmaceuticals practice.

Search by Topic

see all

Is ‘BerkshAmazMorgan’ Testing a Cure for What Ails US Healthcare?

Posted by Pratap Khedkar on Thu, Mar 29, 2018

Paul Darling co-wrote this blog post with Pratap Khedkar.

This is the second post in a two-part series on the recently announced Berkshire Hathaway/Amazon/JPMorgan Chase healthcare venture. 

The U.S. healthcare system is broken. Most healthcare stakeholders now are willing to admit that, and many are actively trying to fix it—or at least starting to talk about what it would take to do so. Many of the recent consolidations and vertical integrations are the involved parties’ attempts at solving for links in the healthcare chain that they previously had no access to, or influence over. Now three giants from corporate America are looking to wade deeper into healthcare delivery to see if they can make some fixes for their employees—and for themselves.

Read More

Topics: Pratap Khedkar, healthcare, vertical integration, healthcare ecosystem, Paul Darling, Amazon, pharmaceutical ads, data and analytics, data strategy, BerkshAmazMorgan, behavior modification, preventive care, healthcare model, employee health and wellness

Subscribe to The Active Ingredient
SUBSCRIBE

Get 'THE ACTIVE INGREDIENT' Updates

Subscribe to receive email notifications whenever new blog posts are published.

×